Temporally precise inhibition of distinct cell types in the intact nervous system has been enabled by the microbial halorhodopsin
NpHR, a fast light-activated electrogenic Cl
− pump. While neurons can be optically hyperpolarized and inhibited from firing action potentials at moderate NpHR expression
levels, we have encountered challenges with pushing expression to extremely high levels, including apparent intracellular
accumulations. We therefore sought to molecularly engineer NpHR to achieve strong expression without these cellular side effects.
We found that high expression correlated with endoplasmic reticulum (ER) accumulation, and that under these conditions NpHR
colocalized with ER proteins containing the KDEL ER retention sequence. We screened a number of different putative modulators
of membrane trafficking and identified a combination of two motifs, an N-terminal signal peptide and a C-terminal ER export
sequence, that markedly promoted membrane localization and ER export defined by confocal microscopy and whole-cell patch clamp.
The modified NpHR displayed increased peak photocurrent in the absence of aggregations or toxicity, and potent optical inhibition
was observed not only
in vitro but also
in vivo with thalamic single-unit recording. The new enhanced NpHR (eNpHR) allows safe, high-level expression in mammalian neurons,
without toxicity and with augmented inhibitory function,
in vitro and
in vivo.
Viviana Gradinaru and Kimberly R. Thompson contributed equally to this work.